Xinjian Qu
Overview
Explore the profile of Xinjian Qu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Q, Wang Z, Jiang C, Yin J, Liu Y, Qu X, et al.
Mar Drugs
. 2025 Feb;
23(2).
PMID: 39997200
(TM) is an opportunistic pathogenic fungus that mainly infects immunocompromised patients. Currently, the global prevalence of talaromycosis caused by TM is increasing, leading to an increased demand for anti-TM drugs....
2.
Jiang C, Feng G, Wang Z, Liu K, Qu X, Liu Y, et al.
J Appl Microbiol
. 2024 Dec;
135(12).
PMID: 39656856
Aims: The present study aims to investigate the in vitro antifungal activity and mechanism of action of bamemacrolactine C (BAC), a new 24-membered macrolide compound, against Talaromyces marneffei. Methods And...
3.
Duan A, Qu X, Lin Q, Qin G, Zhao X, Li S, et al.
Chem Biodivers
. 2024 Nov;
:e202402158.
PMID: 39562509
Pipefish is traditionally used as a male tonic in China. Recent studies have shown that Syngnathus schlegeli extracts effectively combat benign prostatic hyperplasia (BPH). However, the specific active compounds involved...
4.
Xu C, Cao G, Zhang H, Bai M, Yi X, Qu X
Mar Drugs
. 2024 Jun;
22(6).
PMID: 38921586
Cyclic pentapeptide compounds have garnered much attention as a drug discovery resource. This study focused on the characterization and anti-benign prostatic hyperplasia (BPH) properties of avellanin A from fungus in...
5.
Qu X, Xu C, Yang W, Li Q, Tu S, Gao C
Cancer Biomark
. 2024 Jan;
39(3):231-243.
PMID: 38217587
Background: Epithelial-mesenchymal transition (EMT) is an important biological process by which malignant tumor cells to acquire migration and invasion abilities. This study explored the role of KLF5 in the EMT...
6.
Jiang S, Qu X, Liu S, Wei J, Yi X, Liu Y, et al.
Mar Drugs
. 2023 Feb;
21(2).
PMID: 36827152
() is a marine animal and traditional Chinese medicine. plasma is a valuable resource for important medical and health-based functions. In this experiment, in order to evaluate the effect and...
7.
Tu S, Zhang H, Qu X
Cancer Biomark
. 2022 Mar;
34(4):571-582.
PMID: 35342080
Background: With the rapid development of genomics and molecular biology, not only have biochemical indicators been used as tumour markers, but many new molecular markers have emerged. Epigenetic abnormalities are...
8.
Qu X, Hu Y, Wang H, Song H, Young M, Xu F, et al.
ACS Appl Bio Mater
. 2022 Jan;
2(4):1456-1463.
PMID: 35026920
Small interfering RNA (siRNA)-based therapeutics have the potential to treat a series of hereditary and acquired diseases. However, one serious obstacle for siRNA therapy is the lack of an efficient...
9.
Tu S, Zhang H, Yang X, Wen W, Song K, Yu X, et al.
Cancer Biomark
. 2021 Jun;
32(3):303-315.
PMID: 34151839
Background: Since the molecular mechanisms of cervical cancer (CC) have not been completely discovered, it is of great significance to identify the hub genes and pathways of this disease to...
10.
Qu X, Li Q, Tu S, Yang X, Wen W
Mol Biol Rep
. 2021 Jun;
48(6):5023-5032.
PMID: 34146197
E74-like factor five (ELF5) is a basic transcription factor that plays a key role in breast tissue and gland development. However, the molecular mechanism of ELF5 in breast cancer cells...